These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7018556)

  • 1. A cross-matching procedure for the selection of platelet donors for alloimmunized patients.
    Waters AH; Minchinton RM; Bell R; Ford JM; Lister TA
    Br J Haematol; 1981 May; 48(1):59-68. PubMed ID: 7018556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
    Sintnicolaas K; Löwenberg B
    Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of HLA antibodies by platelet crossmatching techniques.
    McGrath K; Holdsworth R; Veale M; Bishop J; Wolf M
    Transfusion; 1988; 28(3):214-6. PubMed ID: 3285524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Mou LL; Deng JM
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):228-36. PubMed ID: 1646671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
    Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
    Vox Sang; 2004 Nov; 87(4):291-8. PubMed ID: 15585026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet crossmatching with lymphocytotoxicity test: an effective method in alloimmunized Chinese patients.
    Chow MP; Yung CH; Hu HY; Tzeng JL; Lin WM; Lin CK
    Transfusion; 1991 Sep; 31(7):595-9. PubMed ID: 1891789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.
    Kickler TS; Ness PM; Braine HG
    Am J Clin Pathol; 1988 Jul; 90(1):69-72. PubMed ID: 3389345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microplate ELISA for the detection of platelet alloantibodies: comparison with the platelet immunofluorescence test.
    Sintnicolaas K; van der Steuijt KJ; van Putten WL; Bolhuis RL
    Br J Haematol; 1987 Jul; 66(3):363-7. PubMed ID: 3304393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
    JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establish a Graded Method to Avoid HLA Class I Antibodies Corresponding Antigen and Combining HLAMatchmaker Application in Improving the CCI Value after Platelet Transfusion for Patients with IPTR].
    Gao SQ; Xu YP; Luo CR; Li DC; Pen L; Liu T; Zou QC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):242-249. PubMed ID: 38387929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients.
    Freedman J; Gafni A; Garvey MB; Blanchette V
    Transfusion; 1989; 29(3):201-7. PubMed ID: 2493693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for alloantibodies in the serum of patients receiving platelet transfusions: a comparison of the ELISA, lymphocytotoxicity, and the indirect immunofluorescence method.
    Levin MD; de Veld JC; van der Holt B; van't Veer MB
    Transfusion; 2003 Jan; 43(1):72-7. PubMed ID: 12519433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Random donor platelet crossmatching: comparison of four platelet antibody detection methods.
    Freedman J; Garvey MB; Salomon de Friedberg Z; Hornstein A; Blanchette V
    Am J Hematol; 1988 May; 28(1):1-7. PubMed ID: 3285667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
    Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
    Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-match-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.
    Elhence P; Chaudhary RK; Nityanand S
    Blood Transfus; 2014 Apr; 12(2):180-6. PubMed ID: 24333069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
    Heal JM; Blumberg N; Masel D
    Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy.
    Brubaker DB; Romine M
    Am J Hematol; 1987 Dec; 26(4):341-52. PubMed ID: 3687931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective platelet crossmatching for selection of compatible random donors.
    Freedman J; Hooi C; Garvey MB
    Br J Haematol; 1984 Jan; 56(1):9-18. PubMed ID: 6367808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between donor-recipient lymphocytotoxicity and the transfusion response using HLA-matched platelet concentrates.
    Herzig RH; Terasaki PI; Trapani RJ; Herzig GP; Graw RG
    Transfusion; 1977; 17(6):657-61. PubMed ID: 595123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.
    Friedberg RC; Donnelly SF; Mintz PD
    Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.